Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic vs Brand Name Pegfilgrastim for Neutrophil Recovery after ASCT
NCT05338047Phase 2Completed
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Apr 2022
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in neutropenia, sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Started Apr 2022; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT05338047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05338047.